Advertisement
Screener

COMPASS PATHWAYS PLC (CMPS) Material Contracts

COMPASS PATHWAYS PLC Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-05: Form 10-Q; Exhibit 10.2; Description License Agreement between Fora Operations Limited and COMPASS Pathfinder Limited dated June 1, 2026..
  • 2026-08-05: Form 10-Q; Exhibit 10.1; Description Lease Agreement dated as of June 3, 2026, by and between 30 MONTGOMERY OWNER, LLC and Compass Pathways, Inc..
  • 2026-01-07: Form 8-K; Exhibit 10.1; Description Third Amendment to Loan and Security Agreement, dated as of June 30, 2023, by and among COMPASS Pathways plc and its subsidiaries, the lenders party thereto and Hercules Capital, Inc., in its capacity as administrative agent and collateral agent..
  • 2025-07-31: Form 10-Q; Exhibit 10.2; Description Second Amendment dated July 30, 2025 to the Loan and Security Agreement, dated as of June 30, 2023, by and among the COMPASS Pathways plc, and its subsidiaries, the lenders party thereto and Hercules Capital, Inc., in its capacity as administrative agent and collateral agent.
FiledFormExhibitDescription
2026-08-0510-Q10.2License Agreement between Fora Operations Limited and COMPASS Pathfinder Limited dated June 1, 2026.
2026-08-0510-Q10.1Lease Agreement dated as of June 3, 2026, by and between 30 MONTGOMERY OWNER, LLC and Compass Pathways, Inc.
2026-01-078-K10.1Third Amendment to Loan and Security Agreement, dated as of June 30, 2023, by and among COMPASS Pathways plc and its subsidiaries, the lenders party thereto and Hercules Capital, Inc., in its capacity as administrative agent and collateral agent.
2025-07-3110-Q10.2Second Amendment dated July 30, 2025 to the Loan and Security Agreement, dated as of June 30, 2023, by and among the COMPASS Pathways plc, and its subsidiaries, the lenders party thereto and Hercules Capital, Inc., in its capacity as administrative agent and collateral agent
2025-07-3110-Q10.1License Agreement and Addendum between Fora Space Limited and COMPASS Pathfinder Limited dated June 6, 2025.
2025-05-0810-Q10.4Amendment No. 1 dated April 30, 2025 to Master Research Collaboration Agreement by and among COMPASS Pathfinder Limited, King’s College London and South London and Maudsley NHS Foundation Trust, dated March 22, 2022
2025-05-0810-Q10.3Amended and Restated Employment Agreement dated May 7, 2025 between Compass Pathfinder Limited and Guy Goodwin
2025-05-0810-Q10.2Amendment dated May 7, 2025 to Employment Agreement dated December 6, 2023 between Compass Pathways, Inc. and Teri Loxam
2025-05-0810-Q10.1Amended and Restated Employment Agreement dated May 7, 2025 between Compass Pathfinder Limited and Kabir Nath
2025-02-2710-K10.22Settlement Agreement with Matthew Owens dated December 19, 2024
2025-02-2710-K10.21First Amendment dated October 30, 2024 to the Loan and Security Agreement, dated as of June 30, 2023, by and among the COMPASS Pathways plc, and its subsidiaries, the lenders party thereto and Hercules Capital, Inc., in its capacity as administrative agent and collateral agent
2024-05-0810-Q10.2Employment Agreement dated April 15, 2024 with Kabir Nath
2024-05-0810-Q10.1Employment Agreement with Matthew Owens, as amended effective March 6, 2024
2024-02-2910-K10.26Amendment to Employment Agreement dated August 1, 2023 by and between Kabir Nath and Compass Pathways, Inc. dated August 1, 2023
2024-02-2910-K10.24Employment Agreement dated May 7, 2020 by and between Compass Pathways and Mary-Rose Hughes, as amended
2023-12-078-K10.1Employment Agreement dated December 6, 2023, by and between Compass Pathways and Teri Loxam.
2023-11-0210-Q10.2Lease Agreement between Azul NYC LLC and COMPASS Pathways, Inc. dated September 28, 2023.
2023-10-268-K10.1Separation Agreement dated October 24, 2023 by and between the Company and Michael Falvey.
2023-08-168-K10.1Securities Purchase Agreement, dated August 16, 2023, by and among the Company and the Purchasers
2023-07-058-K10.1Loan and Security Agreement, dated as of June 30, 2023, by and among the COMPASS Pathways plc, and is entered into by and among COMPASS Pathways plc and its subsidiaries, the lenders party thereto and Hercules Capital, Inc., in its capacity as administrative agent and collateral agent.
2023-05-1110-Q10.1License Agreement between Fora Space Limited and COMPASS Pathfinder Limited dated April 4, 2023.
2023-02-2810-K10.19WeWork Membership Agreement dated August 22, 2022 by and between COMPASS Pathways Inc and 130 Madison Avenue Tenant LLC
2023-02-2810-K10.12Restricted share unit award agreement for company employees under the COMPASS Pathways plc 2020 Share Option and Incentive Plan
2022-08-0410-Q10.3Form of Inducement Award Non-Qualified Share Option Agreement.
2022-07-198-K10.2Amendment to Employment Agreement dated September 14, 2020 by and between COMPASS Pathways plc and George Goldsmith.
2022-07-198-K10.1Employment Agreement dated August 1, 2022 by and between COMPASS Pathways plc and Kabir Nath.
2022-05-1010-Q10.1Master Research Collaboration Agreement by and among COMPASS Pathfinder Limited, King’s College London and South London and Maudsley NHS Foundation Trust, dated March 22, 2022
2022-02-2410-K10.22Service Agreement by and between Movassate Family Trust and COMPASS Pathways Inc dated August 3, 2021
2022-02-2410-K10.21Services Agreement by and between BioInnovation Labs LLC and COMPASS Pathways Inc dated January 31, 2022
2022-02-2410-K10.14Employment Agreement with Matthew Owens
2022-02-048-K10.2Form of Non-Qualified Share Option Agreement for Company Employees under the 2020 Share Option and Incentive Plan.
2022-02-048-K10.1Form of Restricted Share Unit Award Agreement for Company Employees under the 2020 Share Option and Incentive Plan.

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
Septerna, Inc. (SEPN)United States$1.783B-63.01
Xencor Inc (XNCR)United States$1.776B-7.33
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82